These results are consistent with previous studies showing that selective inhibitors of nuclear export (SINE) XPO1 antagonists such as KPT-276, KPT-330, and KPT-185 can downregulate c-Myc expression in cancer 27-29. The gene discussed is MYC; the disease is cancer.